Clinical Trial Update: A Study of MEMP1972A in the Prevention of Allergen-Induced Airway Obstruction in Patients With Mild Asthma (SOLARIO) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating MEMP1972A for preventing allergen-induced airway obstruction in adults with mild asthma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• MEMP1972A

Snippet

Sponsor: Genentech, Inc. | Conditions: Asthma | Phase 2 | Status: COMPLETED